Objective: Marrow-stimulation techniques are used by surgeons to repair cartilage lesions although consistent regeneration of hyaline cartilage is rare. We have shown previously that autologous blood can be mixed with a polymer solution containing chitosan in a glycerol phosphate (GP) buffer (chitosaneGP), and that implantation of this polymer/blood composite onto marrow-stimulated chondral defects in rabbit and sheep leads to the synthesis of more chondral repair tissue with greater hyaline character compared to marrow-stimulation alone. In the current study, we examined the modulation of cell recruitment and repair tissue characteristics at early post-surgical time points (from day 1 to 56) in a rabbit model to elucidate potential mechanisms behind this improved repair outcome.
Introduction
Lesions of articular cartilage that extend into subchondral bone have access to multiple cell types that can migrate into the chondral zone of the lesion and synthesize a repair tissue 1, 2 . Orthopedic surgeons have developed marrowstimulation techniques, such as abrasion arthroplasty 3 , drilling 4 and microfracture 5 in order to provide access channels to marrow-derived blood and cells and consequently initiate a wound repair response in cartilage defects. These surgical techniques have met with some success 6 but are thought to mainly produce fibrocartilagenous repair with limited mechanical properties and durability 1 .
Successful wound healing in adult tissues depends on the formation of a blood clot 7 that establishes hemostasis, and generates multiple signals leading to cell recruitment and synthesis of a provisional scaffold for cell migration. Since marrow-stimulation alone does not reproducibly lead to the formation of hyaline repair cartilage, it may be concluded that these procedures do not generate an optimal setting for effective cartilage repair. One potential limitation of these procedures is that the resident blood clot resulting from marrow-stimulation retracts to a small percentage of its original volume via a platelet-mediated process 8, 9 and may be subsequently removed by fluid irrigation. Stabilizing this critical blood clot in the cartilage lesion could improve cartilage repair by providing a physical and chemical environment suitable for migration of progenitor cells and synthesis of repair tissue. With this in mind, we have recently adopted an approach to improve cartilage repair by mixing solubilized chitosan, a biodegradable thrombogenic polymer, with autologous blood. This polymer/ blood mixture is then applied above a marrow-stimulated cartilage defect whereupon it solidifies, adheres and remains voluminous by impeding platelet-mediated clot retraction, in order to more effectively drive subchondral bone-mediated cartilage repair 10, 11 . Chitosan is composed of glucosamine and N-acetylglucosamine monomers, is biocompatible, biodegradable, non-toxic, and has been shown to improve wound healing in connective tissues of several species 12, 13 . Chitosan induces aggregation and activation of platelets 14 and promotes blood coagulation 15, 16 . Furthermore, chitosan is a polycation that can bind to biological surfaces that are rich in anionic glycosaminoglycans 17 , including cartilage 11 , and is therefore particularly promising for orthopedic applications. In dermal wound healing models, chitosan has been found to induce transient chemotaxis of inflammatory cells 18e20 that is often accompanied by an increase in the synthesis of collagen in the granulation tissue 20 , by a process believed to be partly dependent on secretion of growth factors by macrophages 21 . Chitosan is chemoattractive for endothelial cells in vitro 22 and induces angiogenesis in vivo 23 . Similarly as in dermal wound healing models, the stimulatory effects of chitosan on cell recruitment and angiogenesis could promote more effective cartilage repair in lesions that communicate with subchondral bone.
A well known property of chitosan is its solubility at acidic pH (<6) and insolubility at neutral pH, making its use in solution with living cells and tissues problematic. However, glycerol phosphate (GP) buffers can be used to bring chitosan solutions to a cytocompatible near-neutral pH, while maintaining chitosan solubility 24, 25 . We recently demonstrated that mixing of this physiological chitosaneGP solution with whole blood generates a chitosaneGP/blood solution that coagulates in situ within 15 min, when applied to cartilage defects 10, 11 . Furthermore, these coagulated chitosaneGP/blood clots are adhesive and contract much less than whole blood clots, thereby maintaining a voluminous scaffold 10, 11 . ChitosaneGP/blood implants were applied to marrow-stimulated chondral defects in sheep and rabbit cartilage repair models, where they induced greater fill of chondral defects with repair tissue compared to marrow-stimulation alone 11 and, in addition, produced a more cellular and hyaline repair cartilage well integrated with a porous subchondral bone structure 10, 11 . This led us to hypothesize that chitosaneGP/blood clots stimulated specific early events in osteochondral healing that led to more hyaline repair.
In the current study, we have examined cell recruitment and repair tissue characteristics at early post-surgical time points in a rabbit repair model to further understand the influence of these implants on cartilage repair. We tested the hypotheses that chitosaneGP/blood implants would (1) initially reside in the defects and then be completely degraded without generating chronic inflammation, (2) increase bone marrow cell recruitment, (3) increase vascularization of the provisional repair tissue, and (4) modulate subchondral repair tissue development. For this, we used a previously developed rabbit model 10 , where bilateral trochlear cartilage defects were perforated with microdrill holes into the subchondral bone, and then either treated with the chitosaneGP/blood implants or left to bleed from subchondral bone as the control. Implant residency and biodegradation, recruitment of host cells, vascularization of subchondral tissue and osteochondral healing events were assessed with histochemical stains, immunohistochemical collagen typing, and stereology tools at time points ranging from 1 to 56 days postsurgery.
Materials and methods

ANIMALS
Three groups of skeletally mature New Zealand White (NZW) rabbits (Charles River, St. Constant, QC, Canada) housed individually in cages were used for the study (Table I) . The housing, care and study protocol were approved by the Animal Care Committee of the University of Montreal. The animals were randomized according to sex and weight for distribution to treatment group and to each time point. The treated knee (left or right) was also randomized.
PREPARATION OF CHITOSAeGP SOLUTIONS
Chitosans (BioSyntech Inc, Laval, Quebec, Canada) with degree of deacetylation (DDA) between 77% and 83% (Table II) were used to treat the three groups of rabbits. Sterile chitosaneGP solutions were prepared by first dissolving 150 or 170 mg (after drying) chitosan powder in 9 ml of 66 AE 5 mM HCl (VW3202-2, VWR, Mississauga, Ontario, Canada) followed by autoclave sterilization, and addition of 1 ml filter-sterilized 1.35 M disodium b-glycerophosphate (C 3 H 7 Na 2 O 6 PÁ5H 2 O) (G-9891, Sigma, Oakville, Ontario, Canada) to obtain a final chitosaneGP solutions consisting of 1.5% or 1.7% (w/v) chitosan with 135 mM disodium b-glycerophosphate and 59 mM HCl. The chitosan concentration, pH and osmolality of the chitosaneGP solutions used to treat each animal group are indicated in Table II . ChitosaneGP solutions were distributed in 1.18 ml aliquots into sterile, de-pyrogenized 4 cc Wheaton glass vials containing six sterile surgical stainless steel beads (0.39 g each, #9736, Salem Specialty Ball Co, Canton, CT, USA), flash-frozen with liquid nitrogen and stored at À80 C until use. The steel beads aided in mixing with blood during manual shaking as described below.
SURGICAL PROCEDURES
Following intramuscular (IM) injection of an anesthetic cocktail (ketamineexylazineebuprenorphine), the animals were placed under gas anesthesia with 3% isofluranee8% Table I ) received additional puncture of microdrill holes with a 261=2 gauge needle as previously described 10 which promoted bleeding. One knee per rabbit was treated by applying the chitosaneGP/blood mixture (see preparation details below) to the defect. Treatment with the implant vs control was alternated between the right knees and left knees in all groups. Non-resorbable prolene sutures (BEC367251, Dufort Lavigne, Montreal, Quebec, Canada) were used to close the capsule, fascia and skin. The rabbits from group 1 recovered within 1 h post-surgery. In order to prevent sudden movement immediately following surgery, the rabbits from groups 2 and 3 received three sequential IM injections of ketamineexylazine and recovered within 4 h post-surgery. All animals were given twice daily injection of buprenorphine analgesic for 2 days and were allowed unrestricted ambulation. Animals were sacrificed at the designated time points (1e56 days post-surgery) using an overdose of sodium pentobarbital (381, CDMV, St-Hyacinthe, Quebec, Canada). Synovial fluid smears were taken from each knee at necropsy and stained with May-Grü nwald-Giemsa (MG-1L and GS-1L, Sigma, Oakville, Ontario, Canada) to obtain differential leukocyte count. Blood was taken from the rabbits at surgery and immediately prior to sacrifice to obtain complete blood count (CBC), differential leukocyte count and platelet count. One rabbit from group 2 sacrificed at 7 days post-surgery exhibited marked blood and bone marrow neutrophilia as well as increased blood platelet levels when compared to other rabbits. This rabbit was removed from further analysis due to suspicion of infection. No treatment-specific effusions or other overt signs of infection were seen for the remaining rabbits.
PREPARATION AND APPLICATION OF CHITOSANeGP/BLOOD MIXTURE
Immediately prior to mixing and application of the implants, autologous blood was aseptically withdrawn from the rabbit ear artery and 3.5 ml added to the vial containing 1.18 ml sterile chitosaneGP solution and steel beads. For mixing, the vial was closed and shaken vigorously by hand for 10 s. The chitosaneGP/blood mixtures consisted of autologous blood mixed with the chitosaneGP solutions in a 3:1 ratio to yield final concentrations of 0.4% (w/v) chitosan and 34 mM disodium b-glycerophosphate. A 3 cc syringe equipped with an 18 gauge needle was used to withdraw approximately 3 ml of the chitosaneGP/blood solution and one hanging drop of this solution was applied to the drilled cartilage defect [ Fig. 1(B) ]. In 23 of 33 treated defects, the liquid implant flowed outside the defect and was in potential contact with other joint tissues. Coagulation was allowed for 5e8 min before closing the knee. All implants formed a solid clot covering the entire defect before closing the knee.
HISTOPROCESSING AND STAINING OF OSTEOCHONDRAL TISSUES
After sacrifice, the distal portions of the femurs were clipped off using a bone cutter and fixed in 4% (w/v) paraformaldehyde (P-6148, Sigma, Oakville, Ontario, Canada), 0.1 M sodium cacodylate (BP 325-50, Fisher Scientific, StLaurent, Quebec, Canada), pH 7.3 at room temperature C for a further 48 h. The femurs were decalcified in 10% (w/v) ethylenediaminetetraacetic acid (EDTA) (ED4SS, Sigma, Oakville, Ontario, Canada) in PBS with 0.1% (w/v) paraformaldehyde pH 7.2 for 9 weeks at 4 C. The condyles were trimmed off and the trochlea was prepared for cryosectioning as previously described 26 . Cryosections (10e12 mm thickness) were taken (Microm, Model Cryo-Star HM 560 M) and collected on SuperFrost Plus slides (12-550-15, Fisher Scientific, St-Laurent, Quebec, Canada).
For Safranin O/Fast Green staining, the sections were sequentially immersed in 0.04% (w/v) Fast Green (F-7252, Sigma, Oakville, Ontario, Canada) and 0.1% (w/v) Safranin O (S-2255, Sigma, Oakville, Ontario, Canada) in water. For Gomori Trichrome staining, the sections were immersed in 0.6% (w/v) Chromotrope 2R (C-3143, Sigma, Oakville, Ontario, Canada) and 0.3% (w/v) Fast Green in 0.6% (w/v) phosphotungstic acid (P-4006, Sigma, Oakville, Ontario, Canada).
COLLAGEN TYPING OF OSTEOCHONDRAL TISSUES BY IMMUNOHISTOCHEMISTRY
Cryosections were subjected to antigen retrieval 27 by boiling in 10 mM Tris pH 10 and enzymatic pre-treatment with 2.5% (w/v) hyaluronidase EC 3.2.1.35 (H-3506, Sigma, Oakville, Ontario, Canada) in PBS. Sections were blocked with 20% (v/v) goat serum (G-9023, Sigma, Oakville, Ontario, Canada) in PBS with 0.1% Triton X-100 for 60 min at room temperature and incubated with the primary antibody of interest diluted with 10% goat serum in PBS with 0.1% Triton X-100. The primary antibodies were (1) monoclonal anti-collagen type I IgG1 clone COL-1 diluted to 37 mg/ml (C-2456, Sigma, Oakville, Ontario, Canada), (2) monoclonal anti-collagen type II IgG1 diluted 1:10 (II-II6B3, DSHB, Iowa, USA), and (3) monoclonal anti-collagen type X IgM clone COL-10 diluted to 5 mg/ ml (C-7974, Sigma, Oakville, Ontario, Canada). Sections were rinsed and incubated with biotinylated goat antimouse IgG (Fab specific) (B-7151, Sigma, Oakville, Ontario, Canada) diluted to 22 mg/ml with 10% goat serum in PBS with 0.1% Triton X-100 for 60 min at room temperature. Histochemical detection was performed with the Vectastain ABC-Alkaline Phosphatase (AP) system and AP Red Substrate kit (AK-5000 and SK-5100, Vector Laboratories Inc, Burlington, Ontario, Canada). Exclusion of primary antibody or use of isotype-matched immunoglobulin (Ig) resulted in no staining. All sections were counterstained with Weigert Iron Hematoxylin (HT-10-7 and HT-10-9, Sigma, Oakville, Ontario, Canada), rapidly dehydrated in graded ethanol and mounted in Permount mounting medium (SP15-100, Fisher Scientific, St-Laurent, Quebec, Canada).
HISTOMORPHOMETRIC AND STEREOLOGICAL ANALYSES
Digital images of stained sections were acquired with a Zeiss Axiolab microscope equipped with either a Sony analogue camera, a digital Q Imaging MicroPublisher 3.3 RTV camera or a digital Hitachi HV-F22F camera. Software for histomorphometric and stereological analyses included Northern Eclipse (Mississauga, Ontario, Canada) and BIO-QUANT OSTEO (Nashville, TN, USA).
The extent of defect debridement was quantified at 1 day post-surgery (n ¼ 10 defects) by measuring the proportion of the defect covered with calcified cartilage on one Safranin O/Fast Green stained transverse section taken midway between the two pairs of drill holes. The cumulative width of the calcified cartilage (mm) remaining at the base of the defect was measured using manual tracing software Northern Eclipse and then normalized to the total width of the defect (mm).
The following histomorphometric and stereological measures were taken for each knee from two transverse sections, one traversing the proximal set of holes and the other traversing the distal set of holes. All sections were selected from the central areas of the holes. Some degree of sampling bias was therefore present in the measurements involving line or plane stereological probes (Sv, Lv) but not for point stereological probes (Vv), due to tissue anisotropy and non-random orientation of the sections.
To quantify the average thickness of tissues in the defect, a projected tidemark was traced manually on Safranin O/Fast Green stained sections using adjacent intact cartilage on both sides of the defects as a guide. Then, the total area (mm 2 ) of tissue present above the projected tidemark was measured using Northern Eclipse software by thresholding on tissues filling the defect and then normalizing to the width of the defect (mm).
To quantify volume density (Vv ¼ volume per tissue volume) of neutrophils and bone marrow-derived stromal cells in the microdrill holes, point (P) counting was performed on Safranin O/Fast Green stained sections, on 0.11 mm 2 microscopic fields taken at three systematic positions (0.5 mm, 1.25 mm and 2.5 mm below the projected tidemark) in each of the four microdrill holes, and applying Vv ¼ P P cell type / P P total 28 . For each knee, Vv was calculated as the average from 12 fields. The grid size in the microscopic fields was set at 82.28 mm Â 82.28 mm, so that the number of points counted for each cell type in each knee exceeded the minimum stereological requirement of 75e150 points 28 . Neutrophils were identified by nuclear morphology and bone marrow-derived stromal cells by a fibroblast cell shape.
To quantify length density (Lv ¼ length per tissue volume) of subchondral blood vessels (BV) in Gomori Trichrome stained sections, BV cross-sections (Q) were counted in each area of reference (A ref ) consisting of 0.11 mm 2 microscopic fields taken at three systematic positions (0.5 mm, 1.25 mm and 2.5 mm below the projected tidemark) in each of the four microdrill holes, and applying Lv ¼ 2 Â Q/ A ref 28 . For each knee, Lv was calculated as the average from 12 fields. BV were specifically identified by the presence of erythrocytes.
To quantify volume density (Vv) of subchondral cartilage in Safranin O/Fast Green stained sections, the area of subchondral cartilage (mm 2 ) was obtained by thresholding on subchondral cartilage tissue (Safranin O positive) below the projected tidemark using Northern Eclipse software and then normalizing to the total area of subchondral tissue (mm 2 ). To quantify volume density (Vv) of subchondral bone in Gomori Trichrome stained sections, the area of subchondral bone (mm 2 ) was obtained by thresholding on subchondral bone (excluding other subchondral tissues such as clot, fibrous tissue, cartilage and marrow) using BIOQUANT OSTEO software and then normalizing to the total area of subchondral tissue (mm Statistical analyses were performed using the paired Student's t-test (pairing treated and untreated for this bilateral model), analysis of variance (ANOVA) and multivariate ANOVA in the general linear model, after checking for normality of data, as well as using non-parametric tests such as the ManneWhitney U Test and the Wilcoxon matched pairs test, as implemented in Statistica version 6.1 package (Statsoft Inc, Tulsa, OK, USA). Since normal probability plots suggested most data to respect normality and nonparametric tests were for the most part concordant with parametric tests, only results from parametric tests were presented.
Results
CHITOSANeGP/BLOOD CLOTS WERE PRESENT FOR UP TO 1 MONTH POST-SURGERY ChitosaneGP/blood implants were solidified in treated drilled cartilage defects [ Fig. 1(B) ], while the contralateral control defects were drilled and simply allowed to bleed [ Fig. 1(A) ]. At 1 day post-surgery, control and treated defects were equally debrided of calcified cartilage in the zone midway between the drill holes where 53% AE 31 vs . ChitosaneGP implants (I) stained as dark material in the chondral defects interfacing with the clot in the microdrill holes (solid arrowheads) and adhering to treated defects at 1 day (solid arrows) (B). In control defects at 21 days, extensive subchondral cartilage (C) formation was observed (C). By 21 days post-surgery, the implants (I) were still visible in the microdill holes of treated defects where extensive BR and small cartilage (C) islands were also observed (D). At 35 days, cartilage (C) was found at the top of the microdrill holes in control (E) and treated (F) defects. Treated (F) repair tissues were already better integrated with the subchondral bone than in controls (E) due to increased BR with chitosaneGP. 5 Osteoarthritis and Cartilage Vol. jj, No. jj 58% AE 31, respectively, of the defect base was still covered with calcified cartilage. Acute repair events were studied in the sections traversing the microdrill holes where residual calcified cartilage was only present outside the holes. Controls from 1 to 14 days post-surgery contained a fibrin network and blood clot in the defects and microdrill holes [ Fig. 2(A) ]. At these same time points, chitosaneGP implants were detected in treated defects as dense material staining a dark color with Fast Green 29 which interfaced with the clot at the top of the microdrill holes and adhered to the defects [ Fig. 2(B) ]. All but one treated defect (23 of 24) taken between 1 and 14 days post-surgery contained chitosaneGP implant. At 21 days post-surgery, the residual chitosaneGP implant could only be detected subchondrally in the microdrill holes of treated defects [ Fig. 2(D) ], and was not observed at all thereafter at 35 and 56 days. Five microdrill holes from treatment groups 2 and 3, from a total of 128 microdrill holes (32 treated defects with four holes each) contained fibrous capsules at 14, 21 and 35 days post-surgery, some of which enclosed chitosan particles (data not shown). The average thickness of chitosaneGP implants in the chondral region of treated defects was significantly greater than the average thickness of fibrin clots in control defects from 1 to 14 days (P < 0.01 for ANOVA comparing treatment to control taking into account Day as a co-variate and P < 0.05 for paired t-tests on days 1, 3 and 14) (Fig. 3) . At 21 days, the chondral zones of both control and treated defects were almost completely devoid of implant, clot, or repair tissues [ Figs. 2(C, D) , 3]. By 35 days post-surgery, repair tissues of continually increasing thickness were detected in the chondral region of treated and control defects Fig. 3 . The average thickness of chitosaneGP implants in treated defects was significantly greater than the average thickness of regular clots in control defects from 1 to 14 days post-surgery (*P < 0.01 using treatment and day as predictors from day 1 to 14, as well as paired t-tests for days 1, 3 and 14). ChitosaneGP implants and regular blood clots were for the most part degraded by 21 days post-surgery in the chondral area, after which chondral repair tissue of increasing thickness was synthesized in treated and control defects. Data are expressed as mean AE SD with n ¼ At 1 day post-surgery, neutrophils (N) were observed in the chondral region of all treated defects, and some neutrophils were co-localized with chitosan particles and aggregates [ Fig. 4(B) ]. Fewer neutrophils were recruited to the fibrin clots of control defects [ Fig. 4(A) ]. Neutrophils were seldom observed in the subchondral repair tissue of control defects after 7 days [ Fig. 4(C) ] while an abundance of neutrophils was seen between 3 and 21 days in treated defects [ Fig. 4(D) ]. ChitosaneGP/blood implants increased volume density (Vv) of neutrophils in the microdrill holes of treated defects until 21 days post-surgery (P < 0.001 at day 3, P < 0.01 at day 7 and P < 0.05 at day 14 for paired t-tests) [ Fig. 5(A) ]. Synovial fluid leukocyte differential profiles also showed a significant increase in the proportion of neutrophils in treated knees compared to control knees from 3 to 21 days post-surgery, which returned to normal at 35e56 days (data not shown).
Bone marrow-derived stromal cells were observed migrating into the microdrill holes of control and treated defects starting at 7 days [ Fig. 4(C, D) ]. Volume density (Vv) of bone marrow-derived stromal cells was significantly higher in microdrill holes of control defects at 7 days postsurgery (P < 0.05 using the paired t-test), but was higher in treated defects from 14 days post-surgery and thereafter (P < 0.05 using the paired t-test on day 21; also P ¼ 0.072 from ANOVA of days 14e56 using Day as a co-variate) [ Fig. 5(B) ]. Numerical integration of total numbers of stromal cells recruited to sampled sites up to day 56 indicated a net increase of 35% in stromal cells recruited to treated defects vs control.
CHITOSANeGP/BLOOD IMPLANTS INCREASED SUBCHONDRAL VASCULARIZATION
New BV filled with erythrocytes were first observed in the bottom of the microdrill holes of treated and control defects at 7 days post-surgery. By day 14, greater numbers of BV were observed in the provisional repair tissue of microdrill holes below treated defects [ Fig. 6(B, D) ] compared to controls [ Fig. 6(A, C) ]. Length density (Lv) of BV was higher in microdrill holes of treated defects from 14 to 35 days postsurgery (P < 0.05 for ANOVA using all days taking into account Day as a co-variate, while P < 0.05 for the paired ttest at 14 days post-surgery) (Fig. 7) .
CHITOSANeGP/BLOOD IMPLANTS DELAYED AND PARTLY INHIBITED SUBCHONDRAL CARTILAGE FORMATION WHILE PROMOTING SUBCHONDRAL BONE REMODELING (BR)
Subchondral cartilage formation initially occurred in the microdrill holes of six of eight control defects at 14 days [ Fig. 8(A) ]. At 21 days post-surgery, cartilage formation could be observed throughout the microdrill holes of control defects [ Fig. 2(C) ]. Treated defects were almost devoid of subchondral cartilage at 14 days [ Fig. 8(B) ] and only contained small islands of subchondral cartilage at 21 days [ Fig. 2(D) ]. Subchondral cartilage volume density (Vv) was therefore higher in control defects at 14 and 21 days post-surgery (P < 0.05 by the paired t-test at 14 days post-surgery) [ Fig. 9(A) ]. Subchondral cartilage formation was followed by chondrocyte hypertrophy, as revealed by type X collagen immunostaining (data not shown), endochondral ossification and terminal differentiation to bone. By 35 days post-surgery, subchondral cartilage was observed in treated and control defects in equal quantities [ Fig. 9(A) ], near the top of the microdrill holes [ Figs. 2(E, F), 9(A) ].
New woven bone (NWB) formation was initiated in control and treated defects at 7 days, and was initially restricted to the bottom of microdrill holes. Starting at 14 days post-surgery, chitosaneGP/blood implants showed much more extensive remodeling of cancellous bone in areas surrounding the microdrill holes [ Figs. 2(D), 8(D) ]. Treatment was a significant predictor of increased trabecular bone surface density (Sv) below defects from 14 to 56 days post-surgery (P < 0.05 from ANOVA with Day as a co-variate between 14 and 56 days) [ Fig. 9(B) ]. There was no difference in total bone volume density (Vv) between control and treated defects at any time point (data not shown). . Volume density (Vv) of neutrophils (N) in microdrill holes was higher in treated defects up to 21 days post-surgery (A) (*P < 0.05 using Student's t-test). Volume density (Vv) of bone marrowderived stromal cells (S) was higher in microdrill holes of control defects at 7 days post-surgery (*P < 0.05 using the paired t-test) but thereafter was greater in treated defects (*P < 0.05 using the paired t-test on day 21; also P ¼ 0.072 using ANOVA for days 14e56 with Day as a co-variate) (B). Data are expressed as mean AE SD with n ¼ 5 (Day 1, 3, 7), n ¼ 8 (Day 14) and n ¼ 3 (Day 21, 35, 56).
Discussion
The objective of this study was to examine modifications of early events in osteochondral repair following application of chitosaneGP/blood implants in cartilage defects that contain access channels to subchondral bone, in skeletally mature rabbits. Our previous work has established the ability of these implants to increase the volume 11 and hyaline quality of cartilage repair tissue 10, 11 , but key events controlling this improved repair were not previously investigated in detail. Our results here revealed that chitosaneGP/blood implants reside for approximately 3 weeks post-surgery in this rabbit model and that degradation is in part mediated by host-derived neutrophils. During this period, chitosaneGP/blood implants increased subchondral cell recruitment and vascularization in the microdrill holes. Increased BR and new bone formation by an intramembranous pathway were also observed, rather than endochondral ossification requiring a cartilaginous intermediate. These subchondral events preceded cartilage repair tissue synthesis and could explain the previously described significant correlation between porous bone underlying the synthesis of a hyaline repair tissue in the chondral compartment 10 . Microdrilled control defects in this study healed through a similar sequence to that previously reported in rabbit for drill or microfracture holes communicating with the cancellous bone 2, 30, 31 . Healing in the microdrill holes of control defects in our model closely resembled healing of 3-mm diameter osteochondral defects observed previously 2 , starting with blood clot formation, inflammatory and marrowderived stromal cell migration, synthesis of a vascularized granulation tissue, intramembranous bone formation in the deeper regions of the microdrill holes, as well as subchondral cartilage formation followed by endochondral ossification in the more superficial regions of the microdrill holes. In microdrilled cartilage defects of skeletally mature rabbits, these events led to the synthesis of bone in the bony compartment and of principally fibrocartilaginous repair tissue emerging from the microdrill holes into the cartilage compartment 2,10,30,31 . ChitosaneGP implant residency was confirmed by histology in treated defects until 21 days post-surgery (Fig. 2) . In general, more tissue was macroscopically apparent in the treated defects compared to controls, especially around the drill holes, which appeared to anchor the implants. ChitosaneGP clots adhered to defect surfaces at 1 day post-surgery (Fig. 2) , extending the previous finding of adhesion of chitosaneGP implants to the defect surfaces at 2 h postsurgery in sheep microfracture defects 11 . We have previously shown in vitro that chitosaneGP can physically stabilize the blood clot by generating clots that retract less than whole blood clots 10 . Consistent with this observation was our finding here of a greater average thickness of chitosaneGP implants compared to regular clots in control defects until 14 days (Fig. 3) . Interestingly, most of the chitosaneGP implants in treated defects and the regular clots in control defects were degraded by 21 days, and tissue regrowth into the chondral zone occurred thereafter (Figs. 2,  3 ). It appears then that early stages of bone marrow-derived cartilage repair primarily depend on processes occurring in the subchondral bone and that subsequent tissue repair in the chondral zone occurs afterwards by an appositional mechanism, growing up from the subchondral bone.
ChitosaneGP/blood implants increased recruitment of neutrophils to the microdrill holes of treated defects (Figs. 4, 5) and to the synovial fluid of treated knees, possibly due to the chemotactic potential of chitosan demonstrated previously in vitro 32, 33 and in vivo 19, 20 . Neutrophils appeared to migrate mainly from the bone marrow in conjunction with bone marrow-derived stromal cells, but may have also migrated from the vasculature in the granulation repair tissue and from the synovial fluid. Numerous neutrophils were observed co-localizing with chitosan particles and aggregates, suggesting that these cells are mainly responsible for the phagocytosis and degradation of the implants. Some microdrill holes from treated defects contained fibrous tissues surrounding chitosan particles that resolved over time. Fibrous capsules like these have been shown to form around slowly degradable biomaterial implants 34 , suggesting that ideal residency for the chitosan implant may be similar to the residency of the normal clot, as we observed here. Neutrophils are believed to have short life spans, but their survival can be lengthened by certain cytokines 35 . Chitosan scaffolds implanted in soft-tissue of mice elicited a sustained neutrophil presence up to 4 weeks post-implantation 36 . In our model, neutrophil infiltration from the marrow and synovial fluid ceased by 35 days post-surgery in treated defects, coinciding with the complete degradation of the implant.
ChitosaneGP/blood implants increased subchondral vascularization of granulation tissues in treated defects (Figs. 6, 7) consistent with the ability of chitosan to promote endothelial cell migration in vitro 22 and angiogenesis in vivo 23 . Additionally, chitosan has been shown to synergistically increase the proliferative effect of platelet-derived growth factor (PDGF) on vascular smooth muscle cells 37 . In our model, increased vascularization occurred simultaneously with a period of inflammatory cell recruitment, suggesting that these inflammatory cells may secrete factors that promote angiogenesis. Alternately, increased recruitment of marrow-derived stromal cells may affect angiogenesis. Chitosan has been shown to stimulate secretion of the angiogenic chemokine interleukin (IL)-8 by fibroblasts in vitro 38 and may ChitosaneGP/blood implants favored intramembranous bone formation in the microdrill holes (Figs. 8, 9 ) rather than endochondral ossification, perhaps through increased vascularization of the granulation tissue. For example, an increase in blood supply during distraction osteogenesis has been associated with intramembranous bone formation 39 . Angiogenesis in the microdrill holes appeared to be directly related to delayed subchondral cartilage formation. Microdrill holes of control defects had few BV at 14 and 21 days post-surgery and extensive subchondral cartilage formation. In comparison, microdrill holes of treated defects had, on average, twice as many BV, continued angiogenesis and marrow-derived stromal cell recruitment at the same time points. Delayed initiation and displacement of chondrogenesis towards the top of the microdrill holes could explain in part the more columnar and hyaline tissue found in our previous study at 56 days 10 . Although some BR was observed under our control defects, as has been observed under cartilage defects treated with microfracture 40 , chitosaneGP/blood implants increased subchondral BR compared to controls (Figs. 2, 8, 9 ). Other cartilage repair procedures have been reported to induce subchondral bone reactions, leading to a net loss of bone 41 , invasion of the bony compartment with cartilaginous and fibrous tissues 42 , and distortion of the trabecular structure 43 . In contrast, we found focal areas of bone resorption below the implants were quickly replaced with a vascularized granulation repair tissue and NWB. New bone trabeculae were finer and more numerous (Fig. 8) , leading to an increase in trabecular surface density under treated defects (Fig. 9 ) without any apparent increase in bone volume density. The latter is in contrast to increased subchondral bone porosity found at 8 weeks in a more superficial region (250 mm below the tidemark) 10 compared to our more deeply sampled regions here reaching down to 4 mm below the tidemark, reinforcing the importance of accounting for depth when analyzing subchondral bone responses. Of note, an increased number of multinucleated cells, possibly osteoclasts, were observed within bone marrow cavities of defects treated with chitosaneGP/blood implants in our rabbit model at 56 days (unpublished observations), suggesting that remodeling is still on-going at this early end-point. Taken together, these observations suggest that chitosaneGP/ blood implants induce angiogenesis and BR which leads to a porous subchondral bone structure with well vascularized marrow cavities. The presence of this type of porous and vascularized subchondral bone may be essential for effective cartilage repair in methods that rely on bone marrow-mediated cartilage regeneration 10, 11 . Solutions of chitosan in GP can be mixed with freshly drawn autologous blood and applied to debrided cartilage lesions containing conduits to subchondral marrow spaces to facilitate cartilage repair. Previous studies showed that chitosaneGP/blood implants solidify and adhere to cartilage defects, inhibit clot retraction and lead to more chondral repair tissue with greater hyaline quality. The current study added to this knowledge that chitosaneGP/blood implants increase cell recruitment, transient vascularization and remodeling in the subchondral bone region and suggests that these three events are in part responsible for increased quantity and quality of repair tissue in the chondral zone. These results highlight the importance of examining acute and intermediate events in cartilage repair, the predominant role of subchondral bone in effecting cartilage repair, and the potential benefits of adopting a cartilage repair strategy that modulates acute and intermediate events in the subchondral bone in order to improve final cartilage repair outcome.
